iMediSync at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

iMediSync takes part in 2 sessions at CTAD 2026 in Boston. Its program centres on AI analysis of EEG recordings as a biomarker for Alzheimer's disease and Lewy body co-pathology. Its work also covers community screening and photobiomodulation for cognitive impairment.

OrganizationCTAD 2026 Attendance
iMediSync
Seoul, South Korea
imedisync.com
Digital assessment, AI & data
Korean company making AI analysis of EEG brain-wave recordings for dementia screening and mental health.
Talk
Thu Nov 19
4:04pm
Poster

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from iMediSync

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction